The increase in oxidative damage induced by chemotherapeutic drugs participates in killing tumor cells, while upregulation of HO-1 and TRX can effectively resist the oxidative damage faced by cells and inhibit the cytotoxic effect of chemotherapeutic drugs on tumor cells [44–46]. The gene discussed is HMOX1; the disease is neoplasm.